Concussion-focused Scythian sets market debut
By GREGORY ZELLER // Scythian Biosciences Corp. is going public. The New York City/Toronto-based biotech, led by Great Neck investment banker Jonathan Gilbert on its quest to develop the world’s…
Biotech
Throwing in more towels, and that’s very good
By GREGORY ZELLER // Another week, another significant partnership for Applied DNA Sciences, which continues to make itself at home in the national textiles market. The Stony Brook-based provider of…
Award-winning Re-Nuble lays waste to malnutrition
By GREGORY ZELLER // An outer-borough biotech with a Long Island lineage is racing to the head of the organic-fertilizer field. Re-Nuble Inc., founded by scientifically oriented business IT specialist Tinia…
PET project brings Applied DNA to India, and the world
By GREGORY ZELLER // Applied DNA Sciences wants to say one word to you. Just one word. Are you listening? Plastics. After checking cotton, leather, European luxury cars, Department of…
Stock deal, textile team-up top biotech’s big week
By GREGORY ZELLER // It’s been a busy and happy week for Applied DNA Sciences. Just days after trumpeting a new and potentially lucrative research partnership with Texas-based Aloe vera-products…
Applied DNA’s soothing solution to Aloe ‘deception’
By GREGORY ZELLER // In a further display of its unique – some would suggest universal – applicability, Applied DNA Sciences may soon find its way into your favorite facial…
Familiar names abound in Center for Biotech awards
By GREGORY ZELLER // Several breakout research projects – and a few familiar faces from the cutting edge – scored funding this week through Stony Brook University’s annual biotechnology awards…
New federal defense contract bolsters Applied DNA
By GREGORY ZELLER // A new multiyear, seven-figure contract will expand Applied DNA Sciences’ relationship with the Department of Defense. The Stony Brook-based supply-chain, anti-counterfeiting, anti-theft and product-authentication specialist announced…
An SBU sweep in Bioscience Hub’s latest round
By GREGORY ZELLER // Five research projects targeting advanced medical-imaging applications, computer-based drug discoveries and a range of new pharmaceutical treatments will be backed by the Long Island Bioscience Hub….
Big investment, tiny particles and a giant leap for BNL
BY MICHAEL FAIRLIE // Brookhaven National Laboratory is stepping up its electromicroscopy game, in a big way. The fiscal year 2017 New York State budget includes $15 million for the…
Applied DNA goes ‘Beyond’ in cotton quest
By GREGORY ZELLER // Applied DNA Sciences is going to Bed Bath & Beyond, but not because it needs new towels. Instead, the Stony Brook-based provider of DNA-focused supply chain,…
With unique tech, Applied DNA gets into in vitro
By GREGORY ZELLER // A Stony Brook-based biotech has embarked on a five-year mission to safeguard in vitro diagnostics. In vitro studies, sometimes called “test tube experiments,” involve microorganisms, cells…
In protein interactions, it’s the little things that count
Fair warning to the protein complexes behind some of planet Earth’s most nefarious diseases, which have hid from mainstream researchers through decades of molecular science: Stony Brook University is coming for…
Financing set, cannabinoid-concussion study aims high
By GREGORY ZELLER // And now, onto the science. Canadian mining exploration company Kitrinor Metals Inc. and Scythian Biosciences Inc., a Calgary-based biotech owned by Great Neck investment banker Jonathan…
At Applied DNA, they’re really getting into leather
By GREGORY ZELLER // A new international partnership backed by a host of well-known global brands will develop DNA-based security and product-authentication solutions for the leather industries. Stony Brook-based biotech…